Pharmaceutical

Biotech’s road to recovery with 46% increase in Q1 venture funding

Investor optimism in biotech has increased due to the expected lowering of interest rates as inflation slows.

May 29, 2024 - 04:00
Biotech’s road to recovery with 46% increase in Q1 venture funding
Investor optimism in biotech has increased due to the expected lowering of interest rates as inflation slows.
Read the original article

Tags:

Previous Article

Self-amplifying RNA and vaccine innovation: getting from concept to clinic

Next Article

J&J expands atopic dermatitis scope with $1.25bn Numab antibody purchase

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: In early glimpse at data, Akili’s video game shows positive results with adults with ADHD

STAT+: In early glimpse at data, Akili’s video game sho...

May 3, 2023

FDA raises alarm about weight-gain supplement apetamin

FDA raises alarm about weight-gain supplement apetamin

May 6, 2023

STAT+: GSK CEO on pharma giant’s new direction: ‘We’re in the business of preventing and treating disease’

STAT+: GSK CEO on pharma giant’s new direction: ‘We’re ...

Oct 20, 2023